TNFSF14-LTBR pathway plays a vital role in immune responses in the TME of many types of cancer, but this pathway has not been reported in TME of colon cancer, suggesting it might be an important immunotherapeutic target for CRC treatment. The gene discussed is LTBR; the disease is colonic neoplasm.